Objects
D'Amico, Anthony V., Chen, Ming-Hui, Crook, Juanita, Armstrong, John G., Malone, Shawn, Steigler, Allison, Dunne, Mary, Kantoff, Phillip W., Denham, James W.. American Society of Clinical Oncology; 2011. Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancer.
Kishan, Amar U., Sun, Yilun, Armstrong, John G., Nabid, Abdenour, Carrier, Nahtalie, Souhami, Luis, Dunne, Mary T., Efstathiou, Jason A., Sandler, Howard M., Guerrero, Araceli, Joseph, David, Maingon, Philippe, Hartman, Holly, de Reijke, Theo M., Maldonado, X, Ma, TM, Romero, T, Wang, X, Rettig, MB, Reiter, RE, Zaorsky, NG, Steinberg, ML, Nickols, NG, Pisansky, Thomas M., Jia, AY, Garcia, JA, Spratt, DE, Bolla, Michel, Neven, Anouk, Steigler, Allison, Denham, James W., Feng, Felix Y., Zapatero, Almudena. The Lancet Publishing Group; 2022. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.